Amlodipine-induced reversible gum hypertrophy

Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third gen...

Full description

Bibliographic Details
Main Authors: Gutch Manish, Shakya Shobhit, Kumar Sukriti, Annesh Bhattacharjee, Rao Somendra Singh
Format: Article
Language:English
Published: Archives of Global Professionals 2016-01-01
Series:Archives of Pharmacy Practice
Subjects:
Online Access:http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=Manish
_version_ 1819111379546669056
author Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
author_facet Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
author_sort Gutch Manish
collection DOAJ
description Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.
first_indexed 2024-12-22T03:56:41Z
format Article
id doaj.art-9c4a1961517a4a259b276243984bc407
institution Directory Open Access Journal
issn 2045-080X
language English
last_indexed 2024-12-22T03:56:41Z
publishDate 2016-01-01
publisher Archives of Global Professionals
record_format Article
series Archives of Pharmacy Practice
spelling doaj.art-9c4a1961517a4a259b276243984bc4072022-12-21T18:39:51ZengArchives of Global ProfessionalsArchives of Pharmacy Practice2045-080X2016-01-017310310510.4103/2045-080X.186175Amlodipine-induced reversible gum hypertrophyGutch ManishShakya ShobhitKumar SukritiAnnesh BhattacharjeeRao Somendra SinghGingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=ManishAmlodipinecalcium channel blockersgingival hypertrophy
spellingShingle Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
Amlodipine-induced reversible gum hypertrophy
Archives of Pharmacy Practice
Amlodipine
calcium channel blockers
gingival hypertrophy
title Amlodipine-induced reversible gum hypertrophy
title_full Amlodipine-induced reversible gum hypertrophy
title_fullStr Amlodipine-induced reversible gum hypertrophy
title_full_unstemmed Amlodipine-induced reversible gum hypertrophy
title_short Amlodipine-induced reversible gum hypertrophy
title_sort amlodipine induced reversible gum hypertrophy
topic Amlodipine
calcium channel blockers
gingival hypertrophy
url http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=Manish
work_keys_str_mv AT gutchmanish amlodipineinducedreversiblegumhypertrophy
AT shakyashobhit amlodipineinducedreversiblegumhypertrophy
AT kumarsukriti amlodipineinducedreversiblegumhypertrophy
AT anneshbhattacharjee amlodipineinducedreversiblegumhypertrophy
AT raosomendrasingh amlodipineinducedreversiblegumhypertrophy